NCT04840589 2026-03-18Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid TumorsNational Cancer Institute (NCI)Phase 1 Suspended66 enrolled
NCT04851119 2026-02-24Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsChildren's Oncology GroupPhase 1/2 Recruiting147 enrolled